Scarica l'app Stockscreener
2.50
7.41%
-0.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVXL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.70
Aprire:
$2.7
Volume 24 ore:
749.39K
Relative Volume:
0.64
Capitalizzazione di mercato:
$231.68M
Reddito:
-
Utile/perdita netta:
$-39.95M
Rapporto P/E:
-5.3775
EPS:
-0.4649
Flusso di cassa netto:
$-34.08M
1 W Prestazione:
-9.42%
1M Prestazione:
+1.63%
6M Prestazione:
-41.59%
1 anno Prestazione:
-77.64%
Intervallo 1D:
$2.425
$2.71
Intervallo di 1 settimana:
$2.425
$2.79
Portata 52W:
$2.41
$13.99
Anavex Life Sciences Corp Stock (AVXL) Company Profile
Nome
Anavex Life Sciences Corp
Settore
Industria
Telefono
844-689-3939
Indirizzo
630 5TH AVENUE, NEW YORK
Compare AVXL vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corp
|
2.50 | 231.68M | 0 | -39.95M | -34.08M | -0.4649 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Anavex Life Sciences Corp Stock (AVXL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-12-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-23 | Iniziato | Berenberg | Buy |
| 2021-09-23 | Iniziato | BTIG Research | Buy |
| 2020-12-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-09-28 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-02-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-06-18 | Iniziato | Janney | Buy |
| 2018-05-16 | Ripresa | Maxim Group | Buy |
| 2018-03-08 | Iniziato | ROTH Capital | Buy |
| 2018-02-13 | Reiterato | Maxim Group | Buy |
| 2017-09-29 | Ripresa | Noble Financial | Buy |
| 2017-02-07 | Iniziato | Noble Financial | Buy |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
Mostra tutto
Anavex Life Sciences Corp Borsa (AVXL) Ultime notizie
Trading Systems Reacting to (AVXL) Volatility - Stock Traders Daily
AVXL Q1 2026 Earnings: Narrower-than-Expected Loss Drives Stock HigherRevenue Growth Outlook - dars.gov.et
Anavex Life Sciences (AVXL) Jumps 6.98% as Biotech Rally Tests Key Resistance at $2.90TRIN Signal - dars.gov.et
Spotlight On Aldeyra Therapeutics And 2 Other Prominent Penny Stocks - Sahm
CEO transition and delayed SEC filing put Anavex (AVXL) leadership changes in focus - MSN
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
How Anavex Life Sciences Corp. (AVXL) Affects Rotational Strategy Timing - Stock Traders Daily
Anavex Life Sciences Corp. (AVXL) Investigation: Bronstein, Gewir - The National Law Review
Anavex Life Sciences Corp.(NasdaqGS: AVXL) added to Russell 2000 Value Benchmark - marketscreener.com
Anavex Life Sciences Corp.(NasdaqGS:AVXL) added to Russell Microcap Value Benchmark Index - marketscreener.com
Anavex Life Sciences: Waiting On Validation As Blarcamesine Shows Some Promise - Seeking Alpha
AVXL Forecast — Price Target — Prediction for 2027 - TradingView
ETFs Investing in Anavex Life Sciences Corp. Stocks - TradingView
Anavex Life Sciences Corp.(NasdaqGS: AVXL) added to Russell 3000E Value Benchmark - marketscreener.com
Anavex Life Sciences Corp.(NasdaqGS: AVXL) added to Russell 3000 Value Benchmark - marketscreener.com
Anavex Again Sheds Shareholder Suit Over Rett Syndrome Drug - Bloomberg Law News
Enterprise value to revenue forward of Anavex Life Sciences Corp. – NASDAQ:AVXL - TradingView
Anavex Life Sciences Sets 2026 Annual Meeting Date and Proxy Submission Deadline - Minichart
Anavex Life Sciences sets Sept. 24, 2026 annual meeting; July 31 record date, Jul.10 proposal deadline - TradingView
Anavex Life Sciences (NASDAQ: AVXL) schedules 2026 annual meeting and proposal deadlines - Stock Titan
Price to book forward of Anavex Life Sciences Corp. – NASDAQ:AVXL - TradingView
Enterprise value to EBIT forward of Anavex Life Sciences Corp. – NASDAQ:AVXL - TradingView
Price to sales forward of Anavex Life Sciences Corp. – NASDAQ:AVXL - TradingView
Anavex Life Sciences Corp. Actuals & Estimates (BX:12X1) - TradingView
12X1 Forecast — Price Target — Prediction for 2027 - TradingView
Anavex Life Sciences Corp. Actuals & Estimates (FWB:12X1) - TradingView
Anavex Life Sciences Corp (AVXL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anavex Life Sciences Corp (AVXL) Institutional Confidence - TradingKey
Anavex Life Sciences Corp.(NasdaqGS:AVXL) dropped from S&P Biotechnology Select Industry Index - marketscreener.com
Anavex Life Sciences Corp (AVXL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anavex Life Sciences Corp (AVXL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anavex Life Sciences Corp (AVXL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anavex Life Sciences Corp (AVXL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anavex Life Sciences Corp (AVXL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anavex Life Sciences Corp (AVXL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVXL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Alzheimer’s Disease Pipeline Accelerates as 200+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - Barchart
Top 5 Trending Stocks On Stocktwits Today: Webull, SharpLink, Anavex Life Sciences, BigBear.ai, And Oscar Health - MSN
Anavex slips after CEO transition - MSN
Anavex appoints interim CEO following leadership change - Investing.com
AVXL Stock Chart | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
AVXL Technical Analysis & Stock Price Forecast - Intellectia AI
AVXL Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline Amid Clinical Progress - newsline.com
AVXL News | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
AVXL Stock Price, Quote & Chart | ANAVEX LIFE SCIENCES CORP (NASDAQ:AVXL) - ChartMill
MSN Money - MSN
Penny Stocks To Watch In May 2026 - Sahm
Anavex Life Sciences (AVXL) Advances 3% as Stock Approaches Key Resistance LevelEarly Entry Signals - dars.gov.et
Exploring High Growth Tech Stocks In The US Market May 2026 - simplywall.st
AVXLAnavex Life Sciences Corp Short Interest - Finviz
Anavex Life Sciences Corp Azioni (AVXL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):